Effect of palato-pharyngo-plastry on patients with coronary heart disease plus obstructive sleep apnea hypopnea syndrome
10.3760/cma.j.issn.0254-9026.2010.07.013
- VernacularTitle:腭咽成形术对并存阻塞性睡眠呼吸暂停低通气综合征冠心病患者的影响
- Author:
Jiangbo QIN
;
Ning ZHOU
;
Shidong HOU
;
Sheng JIANG
;
Ying ZHAO
- Publication Type:Journal Article
- Keywords:
Sleep apnea,obstructive;
Coronary disease;
Pharyhgostomy;
Continuous positive airuay pressure
- From:
Chinese Journal of Geriatrics
2010;29(7):569-571
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the effect of palato-pharyngo-plastry on patients with coronary heart disease (CHD) plus obstructive sleep apnea hypopnea syndrome (OSAHS). Methods The 113 OSAHS patients with CHD after palato-pharyngo-plastry from January 2001 to December 2006 were enrolled and followed up. The other 125 cases treated with continuous positive airway pressure (CPAP) were as control group. Results The fundmental factors of CHD including cholesterol, triglyeride, fasting blood glucose and body mass index (BM1) showed no statistical differences between two groups (x2 or t= 4.788, 0.479, 0.541, all P>0.05) . Only the oxyhemoglobin saturation during sleep was higher in study group than in control group [(91.2± 2.5)% vs. (87.6±4.2)%, P=0.046]. The angiography showed that 87 cases (77.0%) retained stable, 24 cases (21.2%) became severe in study group. As compared with control group, there were no statistical differences (both P>0.05). 37 cases (32.7%) in study group and 58 cases (46.4%) in control group who suffered from angina became severe with statistical differences between two groups (x2=4.615, P=0.032). The incidences of myocardial infarction and sudden death were lower in study group (3.5% and 0.8%) and in control group (5.6% and 2.4%), showed no statistical, difterences be tween twogroups. x2=0.571 and 0.495, P>0. 05). Conclusions Compared with CPAP, the palato-pharyngo-plastry can improve oxyhemoglobin saturation and reduce angina symptom, but has no better effect on progress of coronary atherosclerosis and acute coronary disease than CPAP.
